HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joaquín Arenas Selected Research

Glycogen Storage Disease Type V (McArdle's Disease)

4/2022Identification of Potential Muscle Biomarkers in McArdle Disease: Insights from Muscle Proteome Analysis.
12/2021Preclinical Research in McArdle Disease: A Review of Research Models and Therapeutic Strategies.
10/2018Missense mutations have unexpected consequences: The McArdle disease paradigm.
1/2018Muscle molecular adaptations to endurance exercise training are conditioned by glycogen availability: a proteomics-based analysis in the McArdle mouse model.
1/2017Low versus high carbohydrates in the diet of the world-class athlete: insights from McArdle's disease.
4/2016Exercise and Preexercise Nutrition as Treatment for McArdle Disease.
2/2016Genes and exercise intolerance: insights from McArdle disease.
1/2016Xanthine Oxidase Pathway and Muscle Damage. Insights from McArdle Disease.
7/2012Knock-in mice for the R50X mutation in the PYGM gene present with McArdle disease.
3/2009Does the K153R variant of the myostatin gene influence the clinical presentation of women with McArdle disease?
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joaquín Arenas Research Topics

Disease

15Glycogen Storage Disease Type V (McArdle's Disease)
04/2022 - 09/2003
9Mitochondrial Diseases (Mitochondrial Disease)
03/2022 - 03/2002
3Muscular Diseases (Myopathy)
04/2022 - 10/2007
3Chronic Progressive External Ophthalmoplegia (Progressive External Ophthalmoplegia)
12/2021 - 02/2008
3Muscle Weakness
09/2017 - 02/2008
3Muscle Hypotonia (Hypotonia)
01/2016 - 02/2009
2MELAS Syndrome (Syndrome, MELAS)
06/2022 - 01/2020
2COVID-19
05/2021 - 01/2021
2Inborn Genetic Diseases (Disease, Hereditary)
01/2021 - 07/2012
2Muscular Dystrophies (Muscular Dystrophy)
01/2016 - 11/2014
2Mitochondrial Myopathies (Mitochondrial Myopathy)
11/2015 - 02/2008
2Osteoarthritis
01/2013 - 02/2011
2Inflammation (Inflammations)
02/2011 - 01/2008
2Ataxia (Dyssynergia)
10/2010 - 02/2008
2Hematuria
02/2008 - 07/2007
2Proteinuria
02/2008 - 07/2007
2Myalgia
02/2008 - 07/2007
1Contracture
04/2022
1Respiratory Insufficiency (Respiratory Failure)
01/2021
1Obesity
01/2021
1Overweight
01/2021
1Uniparental Disomy
11/2020
1Neuroinflammatory Diseases
01/2020
1Hemolytic Anemia
10/2019
1Femoral Fractures (Femoral Fracture)
01/2018
1Failure to Thrive
09/2017
1Kearns-Sayre Syndrome
12/2014
1Glycogen Storage Disease (Glycogenosis)
07/2012
1Recurrent Myoglobinuria
03/2012
1Neuropathy ataxia and retinitis pigmentosa
03/2012
1MERRF Syndrome (Myoclonic Epilepsy and Ragged Red Fibers)
03/2012
1Cardiomyopathies (Cardiomyopathy)
03/2012
1Rheumatoid Arthritis
02/2011
1Parkinson Disease (Parkinson's Disease)
10/2010
1Ophthalmoplegia (External Ophthalmoplegia)
10/2010
1Dysarthria (Spastic Dysarthria)
10/2010
1Ataxia Neuropathy Spectrum
10/2010
1Finnish lethal neonatal metabolic syndrome
08/2010
1Liver Failure
09/2009
1Acidosis
09/2009
1Mitochondrial Encephalomyopathies (Mitochondrial Encephalomyopathy)
02/2009

Drug/Important Bio-Agent (IBA)

14Mitochondrial DNA (mtDNA)IBA
06/2022 - 03/2002
9EnzymesIBA
01/2020 - 03/2002
8Glycogen Phosphorylase (Phosphorylase, Glycogen)IBA
04/2022 - 09/2003
7Protein Isoforms (Isoforms)IBA
04/2022 - 10/2008
7Muscle Form Glycogen Phosphorylase (Myophosphorylase)IBA
01/2018 - 09/2003
6Creatine Kinase (Creatine Phosphokinase)IBA
09/2017 - 07/2007
5Proteins (Proteins, Gene)FDA Link
04/2022 - 03/2003
5Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)IBA
09/2017 - 04/2003
3Lactic Acid (Lactate)FDA LinkGeneric
06/2022 - 03/2002
3GlycogenIBA
12/2021 - 01/2018
2Alanine (L-Alanine)FDA Link
06/2022 - 05/2021
2Biomarkers (Surrogate Marker)IBA
04/2022 - 05/2021
2Apoptosis Inducing FactorIBA
03/2022 - 01/2020
2GelsolinIBA
06/2021 - 01/2021
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
05/2021 - 01/2016
2CarbohydratesIBA
01/2017 - 02/2008
2Choline KinaseIBA
01/2016 - 11/2014
2Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2013 - 02/2011
2Reactive Oxygen Species (Oxygen Radicals)IBA
02/2011 - 03/2003
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2003 - 03/2003
1Branched-Chain Amino AcidsIBA
06/2022
1Glutamic Acid (Glutamate)FDA Link
06/2022
1Glutamine (L-Glutamine)FDA Link
06/2022
1ProteomeIBA
04/2022
1fibroblast growth factor 21IBA
06/2021
1Growth Differentiation Factor 15IBA
06/2021
1CreatinineIBA
05/2021
1Lactate Dehydrogenase 5IBA
05/2021
1AlbuminsIBA
05/2021
1C-Reactive ProteinIBA
05/2021
1Ferritins (Ferritin)IBA
05/2021
1IsoenzymesIBA
05/2021
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
05/2021
1lactate dehydrogenase 3IBA
05/2021
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
01/2021
1Adenosine Triphosphate (ATP)IBA
11/2020
1oligomycin sensitivity-conferring protein (complex V)IBA
01/2020
1Phosphoglycerate Kinase (Kinase, Phosphoglycerate)IBA
10/2019
1TelbivudineFDA Link
11/2015
1Folic Acid (Vitamin M)FDA LinkGeneric
12/2014
1Leucovorin (Folinic Acid)FDA Link
12/2014
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
01/2013
1CytokinesIBA
01/2013
1Nonsense Codon (Nonsense Mutation)IBA
07/2012
1Leu Transfer RNAIBA
03/2012
1Valine (L-Valine)FDA Link
03/2012
1Transfer RNA (tRNA)IBA
03/2012
1coenzyme Q10 (CoQ10)IBA
10/2010
1CatalaseIBA
10/2010
1Glutathione (Reduced Glutathione)IBA
10/2010
1Glutathione PeroxidaseIBA
10/2010
1Peroxidase (Myeloperoxidase)IBA
10/2010
1Superoxide DismutaseIBA
10/2010
1IronIBA
08/2010
1SulfurIBA
08/2010
1MyostatinIBA
03/2009
1Mitochondrial Complex III DeficiencyIBA
02/2009

Therapy/Procedure

1Endurance Training
01/2021
1Activities of Daily Living (ADL)
01/2018